Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does PGE2 act as a mediator for endothelin release?

A O Aktan1, O Büyükgebiz, C Yegen

  • 1Marmara University School of Medicine, Department of Surgery, Istanbul, Turkey.

Prostaglandins, Leukotrienes, and Essential Fatty Acids
|January 1, 1994
PubMed
Summary

Iloprost and a thromboxane synthetase inhibitor reduced endothelin release after intestinal ischemia/reperfusion injury. Prostaglandin E2 may mediate this effect via the cyclooxygenase pathway.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pneumonia severity indices predict prognosis in coronavirus disease-2019.

Respiratory medicine and research·2021
Same author

A new technique of completely diverted tube ileostomy for the protection of colorectal anastomosis: a pilot study.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2019
Same author

DNA repair capacity of the colorectal cancer patients and the correlation between the pathological parameters.

Nigerian journal of clinical practice·2019
Same author

Role of nicotinic acetylcholine receptor subtypes on nicotine's enhancing effect on electrical field stimulation elicited contractile responses in rabbit urine bladder.

European review for medical and pharmacological sciences·2016
Same author

Association of BK Virus Titers With Lymphocyte Count in Renal Transplant Patients.

Transplantation proceedings·2015
Same author

Association of male pattern baldness with angiographic coronary artery disease severity and collateral development.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2015

Area of Science:

  • Gastroenterology
  • Vascular Biology
  • Pharmacology

Background:

  • Intestinal ischemia/reperfusion (IR) injury can lead to significant vascular damage.
  • Endothelin release is a key factor in the pathophysiology of IR injury.
  • Understanding the pathways influencing endothelin release is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the effects of iloprost and a thromboxane synthetase inhibitor (UK 38485) on endothelin release following mesenteric IR injury.
  • To explore the roles of lipid peroxidation and prostaglandin E2 (PGE2) in mediating these effects.

Main Methods:

  • Experimental groups included sham, control, iloprost (ILO), UK 38485 (TSI), and combination (ILO + TSI) treatments.
  • Mesenteric IR injury was induced by clamping the superior mesenteric artery for 30 minutes followed by 90 minutes of reperfusion.

Related Experiment Videos

  • Measurements included portal blood endothelin and intestinal tissue malondialdehyde (MDA), PGE2, and leukotriene C4 (LTC4) levels.

    • Main Results:

    • Both iloprost and UK 38485 reversed the increase in MDA levels, with a synergistic effect observed when used in combination, indicating reduced lipid peroxidation.
    • Endothelin levels were reduced by both iloprost and UK 38485, but without a synergistic effect.
    • Iloprost reversed increased PGE2 levels, while UK 38485 and the combination were ineffective in reducing PGE2.

    Conclusions:

    • Endothelin release following mesenteric IR injury is largely independent of lipid peroxidation and the lipoxygenase pathway.
    • The cyclooxygenase pathway appears to directly influence endothelin release, with PGE2 potentially acting as a mediator.
    • Iloprost and thromboxane synthetase inhibition offer potential therapeutic benefits in managing endothelin-mediated responses to IR injury.